DRG Fingertip insights
보험 플랜, 정책 제한, PBM, 의료 제공자 등 마켓 액세스 의사결정에 필요한 데이터와 인사이트를 제공합니다.
Report
2011년 6월 27일
Formulary Advantages in Immune Biologic Therapies: Health plans’ support for certain drug attributes drive formulary coverage for immune biologic brands
The market for immune biologics has grown increasingly crowded in recent years with the launches of newer brands such as Simponi, Cimzia, and Stelara looking to take share away from longer-marketed pr…
